108 related articles for article (PubMed ID: 7573447)
21. Cholesterol primes vascular smooth muscle to induce Ca2 sensitization mediated by a sphingosylphosphorylcholine-Rho-kinase pathway: possible role for membrane raft.
Morikage N; Kishi H; Sato M; Guo F; Shirao S; Yano T; Soma M; Hamano K; Esato K; Kobayashi S
Circ Res; 2006 Aug; 99(3):299-306. PubMed ID: 16825579
[TBL] [Abstract][Full Text] [Related]
22. Regulation of smooth muscle contraction in rabbit internal anal sphincter by protein kinase C and Ins(1,4,5)P3.
Bitar KN; Hillemeier C; Biancani P; Balazovich KJ
Am J Physiol; 1991 Apr; 260(4 Pt 1):G537-42. PubMed ID: 2018129
[TBL] [Abstract][Full Text] [Related]
23. Effect of sphingosine derivatives on calcium fluxes in thyroid FRTL-5 cells.
Törnquist K; Ekokoski E
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):213-8. PubMed ID: 8166643
[TBL] [Abstract][Full Text] [Related]
24. A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts.
Shirao S; Yoneda H; Shinoyama M; Sugimoto K; Koizumi H; Ishihara H; Oka F; Sadahiro H; Nomura S; Fujii M; Tamechika M; Kagawa Y; Owada Y; Suzuki M
J Cereb Blood Flow Metab; 2015 May; 35(5):835-42. PubMed ID: 25605290
[TBL] [Abstract][Full Text] [Related]
25. Sphingosylphosphorylcholine increases calcium concentration in isolated brain nuclei.
Calcerrada MC; Miguel BG; Catalan RE; Martinez AM
Neurosci Res; 1999 Mar; 33(3):229-32. PubMed ID: 10211767
[TBL] [Abstract][Full Text] [Related]
26. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.
Hemmings DG
Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):18-29. PubMed ID: 16570136
[TBL] [Abstract][Full Text] [Related]
27. Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry.
Snetkov VA; Thomas GD; Teague B; Leach RM; Shaifta Y; Knock GA; Aaronson PI; Ward JP
Hypertension; 2008 Feb; 51(2):239-45. PubMed ID: 18158336
[TBL] [Abstract][Full Text] [Related]
28. Role of MEK-ERK pathway in sphingosylphosphorylcholine-induced cell death in human adipose tissue-derived mesenchymal stem cells.
Jeon ES; Kang YJ; Song HY; Woo JS; Jung JS; Kim YK; Kim JH
Biochim Biophys Acta; 2005 May; 1734(1):25-33. PubMed ID: 15866480
[TBL] [Abstract][Full Text] [Related]
29. Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase.
Afrasiabi E; Blom T; Balthasar S; Törnquist K
Mol Cell Endocrinol; 2007 Aug; 274(1-2):43-52. PubMed ID: 17606321
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cytosolic protein phosphorylation by sphingosylphosphorylcholine.
Pushkareva MYu ; Hannun YA
Biochim Biophys Acta; 1994 Mar; 1221(1):54-60. PubMed ID: 8130276
[TBL] [Abstract][Full Text] [Related]
31. Epithelial membrane protein 2 regulates sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization: Changes of PP2A expression by interaction with alpha4 and caveolin-1 in lung cancer cells.
Lee EJ; Park MK; Kim HJ; Kim EJ; Kang GJ; Byun HJ; Lee CH
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1157-69. PubMed ID: 26876307
[TBL] [Abstract][Full Text] [Related]
32. Involvement of ryanodine receptors in sphingosylphosphorylcholine-induced calcium release from brain microsomes.
Dettbarn C; Betto R; Salviati G; Sabbadini R; Palade P
Brain Res; 1995 Jan; 669(1):79-85. PubMed ID: 7712168
[TBL] [Abstract][Full Text] [Related]
33. Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine.
Altmann C; Steenpass V; Czyborra P; Hein P; Michel MC
Br J Pharmacol; 2003 Jan; 138(1):261-71. PubMed ID: 12522098
[TBL] [Abstract][Full Text] [Related]
34. Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway.
Wang XQ; Mao LJ; Fang QH; Kobayashi T; Kim HJ; Sugiura H; Kawasaki S; Togo S; Kamio K; Liu X; Rennard SI
Prostaglandins Other Lipid Mediat; 2014 Jan; 108():23-30. PubMed ID: 24614064
[TBL] [Abstract][Full Text] [Related]
35. Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species.
Shaifta Y; Snetkov VA; Prieto-Lloret J; Knock GA; Smirnov SV; Aaronson PI; Ward JP
Cardiovasc Res; 2015 Apr; 106(1):121-30. PubMed ID: 25661082
[TBL] [Abstract][Full Text] [Related]
36. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK.
Jeon ES; Lee MJ; Sung SM; Kim JH
J Cell Biochem; 2007 Apr; 100(6):1536-47. PubMed ID: 17131361
[TBL] [Abstract][Full Text] [Related]
37. Paxillin participates in the sphingosylphosphorylcholine-induced abnormal contraction of vascular smooth muscle by regulating Rho-kinase activation.
Zhang Y; Li N; Kobayashi S
Cell Commun Signal; 2024 Jan; 22(1):58. PubMed ID: 38254202
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells.
Kim KH; Kim YM; Lee MJ; Ko HC; Kim MB; Kim JH
Exp Mol Med; 2012 Feb; 44(2):159-66. PubMed ID: 22127053
[TBL] [Abstract][Full Text] [Related]
39. The biological activity of acetylated sphingosylphosphorylcholine derivatives.
Zanglis A; Lianos EA; Demopoulos CA
Int J Biochem Cell Biol; 1996 Jan; 28(1):63-74. PubMed ID: 8624845
[TBL] [Abstract][Full Text] [Related]
40. Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells.
Katayama T; Yoshiyama S; Tanaka H; Wang HH; Nakamura A; Kohama K
J Pharmacol Sci; 2006 Nov; 102(3):339-42. PubMed ID: 17072099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
